Welcome and opening remarks

2 September 2019 (13:00 - 13:05)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Darren Keith McGuire

University of Texas Southwestern Medical Center, Dallas (United States of America)

6 More presentations in this session

Presentation thumbnail

What is the role for SGLT2is for patients with heart failure? A cardiologist’s view

Professor G. Filippatos (Athens, GR)

Presentation thumbnail

SGLT2 Inhibitors - Diabetes or renal drugs?

Professor P. Groop (Helsinki, FI)

Presentation thumbnail

Ertugliflozin and the VERTIS program – What have we learned to date?

Professor L. Leiter (Toronto, CA)

Presentation thumbnail

Questions and answers

Presentation thumbnail

Bringing forward the future of SGLT2 inhibitors in the treatment of patients with diabetes and cardiovascular disease - A roundtable dscussion

Professor P. Groop (Helsinki, FI) Professor D. McGuire (Dallas, US) Professor G. Filippatos (Athens, GR) Professor L. Leiter (Toronto, CA)

Access the full session

Session thumbnail

Evidence-based treatment of patients with SGLT-2is - What do we know and what is missing?

The Event

ESC Congress 2019

2 September 2019 13:00 CET

You may be interested in

Webinar

Prevention of heart failure in diabetic patients at population level

Congress Session

Diabetes, obesity, and heart failure

Webinar

Diabetes and ACS - enhancing post-discharge outcomes after primary PCI

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources